参考文献/References:
[1] 李金明.我国临床分子诊断试剂发展:问题及思考[J].检验医学,2014,29(3):199-201.
Li JM.Problems and thinking of reagents for clinical molecular diagnosis in China[J].Lab Med,2014,29(3):199-201.
[2] 谢小娟,朱 娜,潘晶晶,等.miRNA-148a在膀胱癌组织中的表达及生物信息学分析[J].现代检验医学杂志,2015,30(4):6-9,13.
Xie XJ,Zhu N,Pan JJ,et al.Expression of miRNA 148a in bladder carcinoma tissues and its bioinformatics analysis[J].J Mod Lab Med,2015,30(4): 6-9,13.
[3] 钟秀梅,崔 雷.国外临床数据挖掘研究热点的文献计量学分析[J].医学信息学杂志,2015,36(5):57-63.
Zhong XM,Cui L.Bibliometrics analysis on the hot spots of foreignclinical data mining research[J].J Med Info,2015,36(5):57-63.
[4] 李新刚,余克富,赵志刚.药代动力学/药效动力学研究的文献分析[J].中国临床药理学杂志,2014,30(12):1138-1140.
Li XG,Yu KF,Zhao ZG.Bibliometric analysis of pharmacokinetic/pharmacodynamic study[J].Chin J Clin Pharmacol,2014,30(12):1138-1140.
[5] 李新刚,刘振华,田德蔷,等.个体化给药研究的文献分析[J].中国药房,2014,25(38):3635-3639.
Li XG,Liu ZH,Tian DQ,et al.Literature analysis of personalized medicine[J].Chin Pharm,2014,25(38):3635-3639.
[6] 王 谦,林 萍,孙昌朋,等.医学期刊基金论文比与影响因子等指标的关系及影响因素[J].中国科技期刊研究,2015,26(6):634-638.
Wang Q,Lin P,Sun CP,et al.The relationship and influencing factors of medical journals'funding ratio,impact factor,and other evaluation indexes[J].Chin J Sci Tech Peri,2015,26(6):634-638.
[7] 邱均平,周春雷.发文量和h指数结合的高影响力作者评选方法研究-以图书情报学为例的实证分析[J].图书馆论坛,2008,28(6):44-49.
Qiu JP,Zhou CL.The method of selecting high influence authors using published papers and h-index -a case study of the library and information field[J].Lib Trib,2008,28(6):44-49.
[8] Tomlins SA,Rhodes DR,Perner S,et al.Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer[J].Science,2005,310(5748):644-648.
[9] Levett PN.Leptospirosis[J].Clin Microbiol Rev,2001,14(2):296-326.
[10] Lo YM,Corbetta N,Chamberlain PF,et al.Prese-nce of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485-487.
[11] Henter JI,Horne A,Aricó M,et al.HLH-2004:diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2007,48(2):124-131.
[12] Hamilton SR,Liu B,Parsons RE,et al.The molecular basis of Turcot'ssyndrome[J].N Engl J Med,1995,332(13):839-847.
[13] Richard P,Charron P,Carrier L,et al.Hypertrophic cardiomyopathy:distribution of disease genes,spectrum of mutations,and implications for a molecular diagnosis strategy[J].Circulation,2003,107(17):2227-2232.
[14] Powell SM,Petersen GM,Krush AJ,et al.Molecular diagnosis of familialadenomatous polyposis[J].N Engl J Med,1993,329(27):1982-1987.
[15] Yates CR,Krynetski EY,Loennechen T,et al.Mo-lecular diagnosis of thiopurine S-methyltransferase deficiency:genetic basis for azathioprine and mercaptopurine intolerance[J].Ann Intern Med,1997,126(8):608-614.
[16] Rosenwald A,Wright G,Wiestner A,et al.The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma[J].Cancer Cell,2003,3(2):185-197.
[17] Choi M,Scholl UI,Ji W,et al.Genetic diagnosis by whole exome captureand massively parallel DNA sequencing[J].Proc Natl Acad Sci USA,2009,106(45):19096-19101.